These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 25332207)
21. Hybrid transgenic mice reveal in vivo specificity of G protein-coupled receptor kinases in the heart. Eckhart AD; Duncan SJ; Penn RB; Benovic JL; Lefkowitz RJ; Koch WJ Circ Res; 2000 Jan 7-21; 86(1):43-50. PubMed ID: 10625304 [TBL] [Abstract][Full Text] [Related]
22. Estrogen attenuates left ventricular and cardiomyocyte hypertrophy by an estrogen receptor-dependent pathway that increases calcineurin degradation. Donaldson C; Eder S; Baker C; Aronovitz MJ; Weiss AD; Hall-Porter M; Wang F; Ackerman A; Karas RH; Molkentin JD; Patten RD Circ Res; 2009 Jan; 104(2):265-75, 11p following 275. PubMed ID: 19074476 [TBL] [Abstract][Full Text] [Related]
23. Cooperative Binding of ETS2 and NFAT Links Erk1/2 and Calcineurin Signaling in the Pathogenesis of Cardiac Hypertrophy. Luo Y; Jiang N; May HI; Luo X; Ferdous A; Schiattarella GG; Chen G; Li Q; Li C; Rothermel BA; Jiang D; Lavandero S; Gillette TG; Hill JA Circulation; 2021 Jul; 144(1):34-51. PubMed ID: 33821668 [TBL] [Abstract][Full Text] [Related]
24. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure. Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233 [TBL] [Abstract][Full Text] [Related]
25. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling. Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855 [TBL] [Abstract][Full Text] [Related]
26. Involvement of nuclear factor κB (NF-κB) signaling pathway in regulation of cardiac G protein-coupled receptor kinase 5 (GRK5) expression. Islam KN; Koch WJ J Biol Chem; 2012 Apr; 287(16):12771-8. PubMed ID: 22389501 [TBL] [Abstract][Full Text] [Related]
27. Myocyte redistribution of GRK2 and GRK5 in hypertensive, heart-failure-prone rats. Yi XP; Gerdes AM; Li F Hypertension; 2002 Jun; 39(6):1058-63. PubMed ID: 12052842 [TBL] [Abstract][Full Text] [Related]
28. Cross-talk between calcineurin/NFAT and Jak/STAT signalling induces cardioprotective alphaB-crystallin gene expression in response to hypertrophic stimuli. Manukyan I; Galatioto J; Mascareno E; Bhaduri S; Siddiqui MA J Cell Mol Med; 2010 Jun; 14(6B):1707-16. PubMed ID: 19538478 [TBL] [Abstract][Full Text] [Related]
29. GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy. Lieu M; Koch WJ Expert Opin Ther Targets; 2019 Mar; 23(3):201-214. PubMed ID: 30701991 [TBL] [Abstract][Full Text] [Related]
30. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes. MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982 [TBL] [Abstract][Full Text] [Related]
32. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth. Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416 [TBL] [Abstract][Full Text] [Related]
33. NULP1 Alleviates Cardiac Hypertrophy by Suppressing NFAT3 Transcriptional Activity. Zhang X; Lei F; Wang XM; Deng KQ; Ji YX; Zhang Y; Li H; Zhang XD; Lu Z; Zhang P J Am Heart Assoc; 2020 Aug; 9(16):e016419. PubMed ID: 32805187 [TBL] [Abstract][Full Text] [Related]
34. Stachydrine hydrochloride suppresses phenylephrine-induced pathological cardiac hypertrophy by inhibiting the calcineurin/nuclear factor of activated T-cell signalling pathway. Zheng J; Tian J; Wang S; Hu P; Wu Q; Shan X; Zhao P; Zhang C; Guo W; Xu M; Chen H; Lu R Eur J Pharmacol; 2020 Sep; 883():173386. PubMed ID: 32712088 [TBL] [Abstract][Full Text] [Related]
35. BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy. Shahid M; Spagnolli E; Ernande L; Thoonen R; Kolodziej SA; Leyton PA; Cheng J; Tainsh RE; Mayeur C; Rhee DK; Wu MX; Scherrer-Crosbie M; Buys ES; Zapol WM; Bloch KD; Bloch DB Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H984-94. PubMed ID: 26873969 [TBL] [Abstract][Full Text] [Related]
36. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms. Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648 [TBL] [Abstract][Full Text] [Related]
37. Cardiac anti-remodelling effect of aerobic training is associated with a reduction in the calcineurin/NFAT signalling pathway in heart failure mice. Oliveira RS; Ferreira JC; Gomes ER; Paixão NA; Rolim NP; Medeiros A; Guatimosim S; Brum PC J Physiol; 2009 Aug; 587(Pt 15):3899-910. PubMed ID: 19505981 [TBL] [Abstract][Full Text] [Related]
38. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Streicher JM; Ren S; Herschman H; Wang Y Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119 [TBL] [Abstract][Full Text] [Related]
39. GRK5 Controls SAP97-Dependent Cardiotoxic β Xu B; Li M; Wang Y; Zhao M; Morotti S; Shi Q; Wang Q; Barbagallo F; Teoh JP; Reddy GR; Bayne EF; Liu Y; Shen A; Puglisi JL; Ge Y; Li J; Grandi E; Nieves-Cintron M; Xiang YK Circ Res; 2020 Aug; 127(6):796-810. PubMed ID: 32507058 [TBL] [Abstract][Full Text] [Related]